Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Pulmonary delivery of an ultra-fine oxytocin dry powder formulation: potential for treatment of postpartum haemorrhage in developing countries.

Prankerd RJ, Nguyen TH, Ibrahim JP, Bischof RJ, Nassta GC, Olerile LD, Russell AS, Meiser F, Parkington HC, Coleman HA, Morton DA, McIntosh MP.

PLoS One. 2013 Dec 23;8(12):e82965. doi: 10.1371/journal.pone.0082965. eCollection 2013.

2.

Carbetocin for preventing postpartum haemorrhage.

Su LL, Chong YS, Samuel M.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD005457. doi: 10.1002/14651858.CD005457.pub4. Review.

PMID:
22513931
3.

Carbetocin for preventing postpartum haemorrhage.

Su LL, Chong YS, Samuel M.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD005457. doi: 10.1002/14651858.CD005457.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;(4):CD005457.

PMID:
22336812
4.

Oxytocin agonists for preventing postpartum haemorrhage.

Su LL, Chong YS, Samuel M.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005457. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD005457.

PMID:
17636798
5.

Impact on postpartum hemorrhage of prophylactic administration of oxytocin 10 IU via Uniject™ by peripheral health care providers at home births: design of a community-based cluster-randomized trial.

Stanton CK, Newton S, Mullany LC, Cofie P, Agyemang CT, Adiibokah E, Darcy N, Khan S, Levisay A, Gyapong J, Armbruster D, Owusu-Agyei S.

BMC Pregnancy Childbirth. 2012 Jun 7;12:42. doi: 10.1186/1471-2393-12-42.

6.

Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.

Pantoja T, Abalos E, Chapman E, Vera C, Serrano VP.

Cochrane Database Syst Rev. 2016 Apr 14;4:CD011491. doi: 10.1002/14651858.CD011491.pub2. Review.

PMID:
27078125
7.

Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.

Fabio K, Curley K, Guarneri J, Adamo B, Laurenzi B, Grant M, Offord R, Kraft K, Leone-Bay A.

AAPS PharmSciTech. 2015 Dec;16(6):1299-306. doi: 10.1208/s12249-015-0314-0. Epub 2015 Mar 17.

8.

Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR).

Sentilhes L, Vayssière C, Deneux-Tharaux C, Aya AG, Bayoumeu F, Bonnet MP, Djoudi R, Dolley P, Dreyfus M, Ducroux-Schouwey C, Dupont C, François A, Gallot D, Haumonté JB, Huissoud C, Kayem G, Keita H, Langer B, Mignon A, Morel O, Parant O, Pelage JP, Phan E, Rossignol M, Tessier V, Mercier FJ, Goffinet F.

Eur J Obstet Gynecol Reprod Biol. 2016 Mar;198:12-21. doi: 10.1016/j.ejogrb.2015.12.012. Epub 2015 Dec 21.

PMID:
26773243
9.

Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery.

Rattanupatam T, Srichana T.

Drug Deliv. 2014 Sep;21(6):397-405. doi: 10.3109/10717544.2013.868555. Epub 2014 Jan 8.

PMID:
24401124
10.

Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin.

Rath W.

Eur J Obstet Gynecol Reprod Biol. 2009 Nov;147(1):15-20. doi: 10.1016/j.ejogrb.2009.06.018. Epub 2009 Jul 17. Review.

PMID:
19616358
11.

Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery:a double-blind randomized trial.

Boucher M, Nimrod CA, Tawagi GF, Meeker TA, Rennicks White RE, Varin J.

J Obstet Gynaecol Can. 2004 May;26(5):481-8.

PMID:
15151735
12.

Stabilization of IgG1 in spray-dried powders for inhalation.

Schüle S, Schulz-Fademrecht T, Garidel P, Bechtold-Peters K, Frieb W.

Eur J Pharm Biopharm. 2008 Aug;69(3):793-807. doi: 10.1016/j.ejpb.2008.02.010. Epub 2008 Feb 19.

PMID:
18477504
13.

Carbetocin versus oxytocin for prevention of postpartum hemorrhage in obese nulliparous women undergoing emergency cesarean delivery.

El Behery MM, El Sayed GA, El Hameed AA, Soliman BS, Abdelsalam WA, Bahaa A.

J Matern Fetal Neonatal Med. 2016;29(8):1257-60. doi: 10.3109/14767058.2015.1043882. Epub 2015 May 6.

PMID:
25946576
14.

Postpartum uterine response to oxytocin and carbetocin.

Amsalem H, Aldrich CJ, Oskamp M, Windrim R, Farine D.

J Reprod Med. 2014 Mar-Apr;59(3-4):167-73.

PMID:
24724226
15.
16.
17.

Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.

Sinsuebpol C, Chatchawalsaisin J, Kulvanich P.

Drug Des Devel Ther. 2013 Aug 28;7:861-73. doi: 10.2147/DDDT.S47681. eCollection 2013.

18.

The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules.

Sou T, Kaminskas LM, Nguyen TH, Carlberg R, McIntosh MP, Morton DA.

Eur J Pharm Biopharm. 2013 Feb;83(2):234-43. doi: 10.1016/j.ejpb.2012.10.015. Epub 2012 Nov 23.

PMID:
23183447
19.

Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.

Razavi Rohani SS, Abnous K, Tafaghodi M.

Int J Pharm. 2014 Apr 25;465(1-2):464-78. doi: 10.1016/j.ijpharm.2014.02.030. Epub 2014 Feb 21.

PMID:
24560646
20.

Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: A design of experiment approach.

Sou T, Orlando L, McIntosh MP, Kaminskas LM, Morton DA.

Int J Pharm. 2011 Dec 15;421(2):220-9. doi: 10.1016/j.ijpharm.2011.09.018. Epub 2011 Sep 21.

PMID:
21963471

Supplemental Content

Support Center